On the 11th of last month, a Danish medical team is preparing to receive the AstraZeneca Corona 19 vaccine.▶ Click here for a larger view
Danish authorities reported on the 20th (local time) that two medical workers who were vaccinated against the novel coronavirus infection (Corona 19) of AstraZeneca (AZ) had symptoms of blood clots and cerebral hemorrhage, and one of them died. did.
The remaining one of these two was also in serious condition, authorities said.
Danish health officials confirmed that they had received two serious cases reported that day, and said that both had been vaccinated within 14 days of AZ.
The authorities did not disclose specific information, such as when the two people started getting sick.
Earlier, Denmark announced on the 11th that a 60-year-old woman who received the AZ vaccine in her country died after forming a blood clot, and that it would temporarily suspend its use for two weeks as a preventive measure.
This is the second case of death after AZ vaccination in Denmark, according to the New York Times (NYT).
The European Medicines Agency (EMA), an agency that evaluates medicines and vaccines in the European Union, said on the 18th that blood clots were formed after vaccination with AZ, saying, “The AZ vaccine is safe and the benefit is greater than the risk of side effects.” Among the countries that had withheld AZ vaccination, some countries, such as Germany, France, and Italy, have resumed vaccination this week.
Danish health officials say they need more time to decide whether or not to use the vaccine, Reuters reported.
The authorities said, “We will prioritize cases suspected of serious side effects and thoroughly investigate whether there is any association with the vaccine.”
AstraZeneca, a pharmaceutical company, reaffirmed its position that the safety of the vaccine is a top priority and hopes that the vaccination can be resumed across Europe after a careful decision by regulatory authorities without giving an immediate answer regarding the case of a blood clot in Denmark.
[연합뉴스]
Copyrights ⓒ Yonhap News. Unauthorized reproduction and redistribution prohibited